Ranolazine dihydrochloride, Anti-ischemic agent (ab142942)
Key features and details
- Metabolic modulator and membrane stabilizer. Anti-ischemic agent.
- CAS Number: 95635-56-6
- Purity: > 99%
- Soluble in water to 100 mM and in DMSO to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Ranolazine dihydrochloride, Anti-ischemic agent -
Description
Metabolic modulator and membrane stabilizer. Anti-ischemic agent. -
Alternative names
- ranolazine
- renolazine
-
Biological description
Novel metabolic modulator and membrane stabilizer. Partial fatty acid oxidation inhibitor. Pyruvate dehydrogenase activator. Shifts myocardial energy metabolism towards glucose for ATP production. Inhibits late INa and IKr currents. Anti-ischemic effects in vivo.
-
Purity
> 99% -
CAS Number
95635-56-6 -
Chemical structure
Properties
-
Chemical name
N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide dihydrochloride -
Molecular weight
500.46 -
Molecular formula
C24H33N3O4.2HCl -
PubChem identifier
71279 -
Storage instructions
Store at Room Temperature. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 100 mM and in DMSO to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
Cl.Cl.OC(CN1CCN(CC1)CC(=O)Nc2c(C)cccc2C)COc3ccccc3OC -
Source
Synthetic
-
Research areas
Images
-
Chemical Structure - Ranolazine dihydrochloride, Anti-ischemic agent (ab142942)2D chemical structure image of ab142942, Ranolazine dihydrochloride, Anti-ischemic agent
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (0)
ab142942 has not yet been referenced specifically in any publications.